Australia's largest stock trading and investment forum Australia's #1 stock forum

UNS

0.00%

0.5¢ unilife corporation

Thanks for sharing your thoughts/opinion you are quite right my...

First 152 Last

Share
Profile

Follow
ghonau

174 Posts.

1

05/02/16

14:51

Post #: 16951936
Share

Originally posted by Mataranka ↑

In my very, very humble opinion - "No, not at all ghonau". If you are not familiar with Unilife`s products and what has transpired thus far for this company perhaps spend some time doing so before selling too quickly, if all goes according to "our dreams" . As we see it (apart from the "hiccups" !!) one of UNS`s main problems is it tried to expand too much (R & D). Simply (my understanding) is that there has now been a change in direction on the R & D front. However, I still believe that Unilife`s potential is enormous given the "right" backing. With a little good fortune on our side that would be great if it was a "good deal for us all" with Amgen . In relation to LTSHs, I honestly cannot understand why someone who has bought in at much higher prices (and is still holding) would be continually so negative in this current situation....unless ...???? Let`s hope in the very near future we don`t have to be continually bombarded by such negativity and that those who have stayed strong/weathered the storm, are feeling more at ease. It would be fantastic if we felt comfortable to check on our stock "here and there," and then get on with the really important issues of life, instead of feeling that we "must continually remain informed and vigilant"......now back to the cooking ! Mrs Fluffy

Expand

Thanks for sharing your thoughts/opinion you are quite right my knowledge around this company and its history is limited and all I have found that it used to promising and recommended by lots of adviser in 2013-2014 but not quite sure what happened then.
BTW I am more than happy for the company and all holders to have bright future

UNS Price at posting: 28.0¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

PEC

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas